• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4607200)   Today's Articles (789)   Subscriber (49374)
For: Pavlic M, Libiseller K, Grubwieser P, Rabl W. Cross-reactivity of the CEDIA buprenorphine assay with opiates: an Austrian phenomenon? Int J Legal Med 2005;119:378-81. [PMID: 15834736 DOI: 10.1007/s00414-005-0544-x] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2004] [Accepted: 03/29/2005] [Indexed: 11/24/2022]
Number Cited by Other Article(s)
1
Plattner S, Pavlic M, Pitterl F, Schubert B. Consumption of the Sugar Substitute Stevia Leads to Cross-Reactivity of CEDIA® Buprenorphine II Immunoassay. J Anal Toxicol 2021;45:1052-1057. [PMID: 33104778 DOI: 10.1093/jat/bkaa167] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2020] [Revised: 10/13/2020] [Accepted: 10/21/2020] [Indexed: 11/12/2022]  Open
2
Abou El Hassan M, Colantonio D, Likhodii S, Nassar BA. The analytical performance of six urine drug screens on cobas 6000 and ARCHITECT i2000 compared to LC-MS/MS gold standard. Clin Biochem 2021;93:99-103. [PMID: 33844982 DOI: 10.1016/j.clinbiochem.2021.04.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2020] [Revised: 02/16/2021] [Accepted: 04/03/2021] [Indexed: 11/27/2022]
3
Schubert B, Pitterl F, Saxl B, Pavlic M. A Novel Enzyme Immunoassay for the Detection of Buprenorphine, Norbuprenorphine and Their Glucuronides in Urine. J Anal Toxicol 2019;43:364-368. [PMID: 30753557 DOI: 10.1093/jat/bkz003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2018] [Revised: 11/28/2018] [Accepted: 01/09/2019] [Indexed: 12/15/2022]  Open
4
Boyars L, Guille C. Treatment of Perinatal Opioid Use Disorder. Obstet Gynecol Clin North Am 2018;45:511-524. [DOI: 10.1016/j.ogc.2018.05.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
5
Saleem M, Martin H, Tolya A, Coates P. Do all screening immunoassay positive buprenorphine samples need to be confirmed? Ann Clin Biochem 2017;54:707-711. [PMID: 28121168 DOI: 10.1177/0004563216688489] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
6
Berg JA, Schjøtt J, Fossan KO, Riedel B. Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids. Subst Abuse Rehabil 2015;6:131-9. [PMID: 26604854 PMCID: PMC4630205 DOI: 10.2147/sar.s88935] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]  Open
7
Nelson ZJ, Stellpflug SJ, Engebretsen KM. What Can a Urine Drug Screening Immunoassay Really Tell Us? J Pharm Pract 2015;29:516-26. [PMID: 25917168 DOI: 10.1177/0897190015579611] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
8
Snyder ML, Melanson SEF. Drug addiction or false conviction? Clin Chem 2014;60:1480-3. [PMID: 25432992 DOI: 10.1373/clinchem.2013.216861] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
9
Saitman A, Park HD, Fitzgerald RL. False-positive interferences of common urine drug screen immunoassays: a review. J Anal Toxicol 2014;38:387-96. [PMID: 24986836 DOI: 10.1093/jat/bku075] [Citation(s) in RCA: 180] [Impact Index Per Article: 18.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
10
Belsey SL, Couchman L, Flanagan RJ. Buprenorphine Detection in Urine Using Liquid Chromatography–High-Resolution Mass Spectrometry: Comparison with Cloned Enzyme Donor Immunoassay (ThermoFisher) and Homogeneous Enzyme Immunoassay (Immunalysis). J Anal Toxicol 2014;38:438-43. [DOI: 10.1093/jat/bku060] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
11
Snyder ML, Darragh A, Flood JG, Jones J, Ropar K, Jarolim P, Melanson SE. Improved Buprenorphine Immunoassay Performance After Urine Treatment with β-Glucuronidase. J Anal Toxicol 2014;38:375-9. [DOI: 10.1093/jat/bku045] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
12
Birch MA, Couchman L, Pietromartire S, Karna T, Paton C, McAllister R, Marsh A, Flanagan RJ. False-Positive Buprenorphine by CEDIA in Patients Prescribed Amisulpride or Sulpiride. J Anal Toxicol 2013;37:233-6. [DOI: 10.1093/jat/bkt016] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]  Open
13
Lin HR, Chen CL, Huang CL, Chen ST, Lua AC. Simultaneous determination of opiates, methadone, buprenorphine and metabolites in human urine by superficially porous liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2013;925:10-5. [PMID: 23507455 DOI: 10.1016/j.jchromb.2013.02.020] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2012] [Revised: 02/19/2013] [Accepted: 02/20/2013] [Indexed: 11/16/2022]
14
Melanson SE. The Utility of Immunoassays for Urine Drug Testing. Clin Lab Med 2012;32:429-47. [DOI: 10.1016/j.cll.2012.06.004] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
15
Melanson SEF, Snyder ML, Jarolim P, Flood JG. A New Highly Specific Buprenorphine Immunoassay for Monitoring Buprenorphine Compliance and Abuse. J Anal Toxicol 2012;36:201-6. [DOI: 10.1093/jat/bks003] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
16
Comparison of 3 Point-of-Care and 2 Automated Urine Buprenorphine Assays for Screening Patients Treated for Chronic Pain. POINT OF CARE 2011. [DOI: 10.1097/poc.0b013e31821c699a] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
17
‘False-positive’ and ‘false-negative’ test results in clinical urine drug testing. Bioanalysis 2009;1:937-52. [DOI: 10.4155/bio.09.81] [Citation(s) in RCA: 52] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
18
Wu MY, Wang YS, Lin CC, Lin DL, Su LW, Huang MH, Liu RH. An empirical study on the selection of analytes and corresponding cutoffs for immunoassay and GC–MS in a two-step test strategy—buprenorphine example. Analyst 2009;134:1848-56. [DOI: 10.1039/b902137j] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
19
False negative result for amphetamines on the Triage® Drug of Abuse panel? Int J Legal Med 2008;123:247-52. [DOI: 10.1007/s00414-008-0304-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2008] [Accepted: 11/14/2008] [Indexed: 10/21/2022]
20
Twigger S, Fox E, Allen K. Measurement of buprenorphine in urine: immunoassay versus LC-MS/MS. Ann Clin Biochem 2008;45:339. [DOI: 10.1258/acb.2008.007250] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
21
Teske J, Weller JP, Larsch K, Tröger HD, Karst M. Fatal outcome in a child after ingestion of a transdermal fentanyl patch. Int J Legal Med 2006;121:147-51. [PMID: 17115172 DOI: 10.1007/s00414-006-0137-3] [Citation(s) in RCA: 65] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2006] [Accepted: 09/25/2006] [Indexed: 01/01/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA